The role of magnetic resonance imaging in diagnosis and management of breast cancer

Technology in Cancer Research and Treatment

Volumn 3, Issue 6, 2004, Pages 527-541

  Pavic, Dag ^a   Koomen, Marcia A ^a   Kuzmiak, Cherie M ^a   Lee, Y H ^a   Pisano, Etta D ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Cancer screening; Magnetic resonance imaging; MRI guided intervention

Indexed keywords

GADOLINIUM;

ADJUVANT CHEMOTHERAPY; BREAST CANCER; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER STAGING; ECHOGRAPHY; HUMAN; LYMPH NODE; LYMPH NODE BIOPSY; MAMMOGRAPHY; MEDICAL LITERATURE; MEDICAL TECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PERFUSION; PREOPERATIVE EVALUATION; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SPECTROSCOPY;

EID: 11144278685     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460400300602     Document Type: Review

References (121)

1. Heywang, S. H., Bassermann, R., Fenzl, G., Nathrath, W., Hahn, D., Beck, R., Krischke, I., and Eiermann, W. MRI of the Breast - Histopathologic Correlation. Eur. J. Radiol. 7, 175-182 (1987).
2. El Yousef, S. J. and Duchesneau, R. H. Magnetic Resonance Imaging of the Human Breast: A Phase I Trial. Radiol. Clin. North. Am. 22, 859-868 (1984).
3. Dash, N., Lupetin, A. R., Daffner, R. H., Deeb, Z. L., Sefczek, R. J., and Schapiro, R. L. Magnetic Resonance Imaging in the Diagnosis of Breast Disease. Am. J. Roentgenol. 146, 119-125 (1986).
4. Heywang, S. H., Hahn, D., Schmidt, H., Krischke, I., Eiermann, W., Bassermann, R., and Lissner, J. MR Imaging of the Breast Using Gadolinium-DTPA. J. Comput. Assist. Tomogr. 10, 199-204 (1986).
5. Sardanelli, F., Lozzelli, A., and Fausto, A. MR Imaging of the Breast: Indications, Established Technique, and New Directions. Eur. Radiol. 13 Suppl 3, 28-36 (2003).
6. Niendorf, H. P., Alhassan, A., Geens, V. R., and Clauss, W. Safety Review of Gadopentetate dimeglumine. Extended Clinical Experience after more than Five Million Applications. Invest. Radiol. 29 Suppl 2, S179-182 (1994).
7. Sardanelli, F., Mancardi, G., and Filippi, M. Safety of the Long-time Monthly Triple Dose of a Gd-based Contrast Agent. Eur. Radiol. 13 Suppl 4, L243-244 (2003).
8. Haustein, J., Laniado, M., Niendorf, H. P., Louton, T., Beck, W., Planitzer, J., Schoffel, M., Reiser, M., Kaiser, W., and Schorner, W. Triple-dose Versus Standard-dose Gadopentetate dimeglumine: A Randomized Study in 199 Patients. Radiology 186, 855-860 (1993).
9. Okada, S., Katagiri, K., Kumazaki, T., Yokoyama, H. Safety of Gadolinium Contrast Agent in Hemodialysis Patients. Acta. Radiol. 42, 339-341 (2001).
10. Heywang-Kobrunner, S. H., Bick, U., Bradley, W. G. Jr., Bone, B., Casselman, J., Coulthard, A., Fischer, U., Muller-Schimpfle, M., Oellinger, H., Patt, R., Teubner, J., Friedrich, M., Newstead, G., Holland, R., Schauer, A., Sickles, E. A., Tabar, L., and Waisman, J., Wernecke, K. D. International Investigation of Breast MRI: Results of a Multicentre Study (11 sites) Concerning Diagnostic Parameters for Contrast-Enhanced MRI Based on 519 Histopathologically Correlated Lesions. Eur. Radiol. 11, 531-546 (2001).
11. Nunes, L. W., Schnall, M. D., and Orel, S. G. Update of Breast MR Imaging Architectural Interpretation Model. Radiology 219, 484-494 (2001).
12. Ikeda, O., Yamashita, Y., Morishita, S., Kido, T., Kitajima, M., Okamura, K., Fukuda, S., and Takahashi, M. Characterization of Breast Masses by Dynamic Enhanced MR Imaging. A Logistic Regression Analysis. Acta. Radiol. 40, 585-592 (1999).
13. th ed. Reston, VA: American College of Radiology (2003).
14. Baum, F., Fischer, U., Vosshenrich, R., and Grabbe, E. Classification of Hypervascularized Lesions in CE MR Imaging of the Breast. Eur. Radiol. 12, 1087-1092 (2002).
15. Orel, S. G. Differentiating Benign from Malignant Enhancing Lesions Identified at MR Imaging of the Breast: Are Time-Signal Intensity Curves an Accurate Predictor? Radiology 211, 5-7 (1999).
16. Del Maschio, A., De Gaspari, A., and Panizza P. Present Indications for the Use of Breast MRI. J. Exp. Clin. Cancer. Res. 21 Suppl. 3, 55-58 (2002).
17. Lee, C. H. and Weinreb, J. C. The Use of Magnetic Resonance Imaging in Breast Cancer Screening Volume 1, Issue 3, 176-182 (2004).
18. Offodile, R. S., Daniel, B. L., Jeffrey, S. S., Wapnir, I., Dirbas, F. M., and Ikeda, D. M. Magnetic Resonance Imaging of Suspicious Breast Masses Seen on One Mammographic View. Breast J. 10, 416-422 (2004).
19. Pfleiderer, S. O., Sachse, S., Sauner, D., Marx, C., Malich, A., Wurdinger, S., Kaiser, W. A. Changes in Magnetic Resonance Mammography Due to Hormone Replacement Therapy. Breast Cancer Res. 6, R232-238 (2004).
20. Fischer, U., Zachariae, O., Baum, F., Von Heyden, D., Funke, M., and Liersch, T. The Influence of Preoperative MRI of the Breasts on Recurrence Rate in Patients with Breast Cancer. Eur. Radiol. Jul 10 2004 [Epub ahead of print].
21. Turetschek, K., Huber, S., Helbich, T., Floyd, E., Tarlo, K. S., Roberts, T. P., Shames, D. M., Wendland, M. F., and Brasch, R. C. Dynamic MRI Enhanced with Albumin-(Gd-DTPA)30 or Ultrasmall Superparamagnetic Iron Oxide Particles (NC100150 Injection) for the Measurement of Microvessel Permeability in Experimental Breast Tumors. Acad. Radiol. 9 Suppl 1, S112-114 (2002).
22. Lee, J. W., Moon, W. K., Weinmann, H.-J., Kim, S. J., Kim, J. H., Park, S. H., Kim, T. J., Yoon, C. J., Kim, Y. H., Cho, E. Y., Ha, S. W., Kang, W.-S., and Chang, K. H. Contrast-enhanced MR Imaging of Postoperative Scars and VX2 Carcinoma in Rabbits: Comparison of Macromolecular Contrast Agent and Gadopentetate Dimeglumine1. Radiology 229, 132-139 (2003).
23. Furman-Haran, E.., Kelcz, F., and Degani, H. Magnetic Resonance Imaging of Breast Cancer Angiogenesis: A Review. J. Exp. Clin. Cancer Res. 21, 47-54 (2002).
24. nd edition. Springer-Verlag, Berlin (1995).
25. Ikeda, O., Nishimura, R., Miyayama, H., Yasunaga, T., Ozaki, Y., Tuji, A., and Yamashita, Y. Evaluation of Tumor Angiogenesis Using Dynamic Enhanced Magnetic Resonance Imaging: Comparison of Plasma Vascular Endothelial Growth Factor, Hemodynamic, and Pharmacokinetic Parameters. Acta. Radiol. 45, 446-452 (2004).
26. Frouge, C., Guinebretiere, J. M., Contesso, G., Di Paola, R., and Blery, M. Correlation Between Contrast Enhancement in Dynamic Magnetic Resonance Imaging of the Breast and Tumor Angiogenesis. Invest. Radiol. 29, 1043-1049 (1994).
27. Buadu, L. D., Murakami, J., Murayama, S., Hashiguchi, N., Sakai, S., Masuda, K., Toyoshima, S., Kuroki, S., and Ohno, S. Breast Lesions: Correlation of Contrast Medium Enhancement Patterns on MR Images with Histopathologic Findings and Tumor Angiogenesis. Radiology 200, 639-649 (1996).
28. Poptani, H., Bansal, N., Graham, R. A., Mancuso, A., Nelson, D. S., and Glickson, J. D. Detecting Early Response to Cyclophosphamide Treatment of RIF-1 Tumors using Selective Multiple Quantum Spectroscopy (SelMQC) and Dynamic Contrast Enhanced Imaging. NMR Biomed. 16, 102-111 (2003).
29. Bhujwalla, Z. M., Shungu, D. C., and Glickson, J. D. Effects of Blood Flow Modifiers on Tumor Metabolism Observed In Vivo by Proton Magnetic Resonance Spectroscopic Imaging. Magn. Reson. Med. 36, 204-211 (1996).
30. Less, J. R., Posner, M. C., Boucher, Y., Borochovitz, D., Wolmark, N., and Jain R. K. Interstitial Hypertension in Human Breast and Colorectal Tumors. Cancer Res. 52, 6371-6374 (1992).
31. Fischer, U., Kopka, L., and Grabbe, E. Breast Carcinoma: Effect of Preoperative Contrast-enhanced MR Imaging on the Therapeutic Approach. Radiology 213, 881-888 (1999).
32. Nunes, L. W., Schnall, M. D., Orel, S. G., Hochman, M. G., Langlotz, C. P., Reynolds, C. A., and Torosian, M. H. Correlation of Lesion Appearance and Histologic Findings for the Nodes of a Breast MR Imaging Interpretation Model. Radiographics 19, 79-92 (1999).
33. Nunes, L. W., Schnall, M. D., Orel, S. G., Hochman, M. G., Langlotz, C. P., Reynolds, C. A., and Torosian, M. H. Breast MR Imaging: Interpretation Model. Radiology 202, 833-841 (1997).
34. Kuhl, C. K., Mielcareck, P., Klaschik, S., Leutner, C., Wardelmann, E., Gieseke, J., and Schild, H.H. Dynamic Breast MR Imaging: Are Signal Intensity Time Course Data Dseful for Differential Diagnosis of Enhancing Lesions? Radiology 211, 101-110 (1999).
35. Ikeda, D. M., Hylton, N. M., Kinkel, K., Hochman, M. G., Kuhl, C. K., Kaiser, W. A., Weinreb, J. C., Smazal, S. F., Degani, H., Viehweg, P., Barclay, J., and Schnall, M. D. Development, Standardization, and Testing of a Lexicon for Reporting Contrast-enhanced Breast Magnetic Resonance Imaging Studies. J. Magn. Reson. Imaging 13, 889-895 (2001).
36. American College of Radiology Website: http://www.acr.org/dyna/?doc= departments/stand_accred/standards/ standards.html Accessed on Sep 7 2004.
37. Vomweg, T. W., Teifke, A., Kunz, R. P., Hintze, C., Hlawatsch, A., Kern, A., Kieitner, K. F., and Thelen, M. Combination of Low and High Resolution Sequences in Two Orientations for Dynamic Contrast-enhanced MRI of the Breast: More than a Compromise. Eur. Radiol. 14, 1732-1742 (2004).
38. Liberman, L., Morris, E. A., Lee, M. J., Kaplan, J. B., LaTrenta, L. R., Menell, J. H., Abramson, A. F., Dashnaw, S. M., Ballon, D. J., and Dershaw, D. D. Breast Lesions Detected on MR Imaging: Features and Positive Predictive Value. Am. J. Roentgenol. 179, 171-178 (2002).
39. Schnall, M. D., Rosten, S., Englander, S., Orel, S. G., and Nunes, L. W. A Combined Architectural and Kinetic Interpretation Model for Breast MR Images. Acad. Radiol. 8, 591-597 (2001).
40. Sickles, E. A. Periodic Mammographic Follow-up of Probably Benign Lesions: Results in 3,184 Consecutive Cases. Radiology 179, 463-468 (1991).
41. Kim, S. J., Morris, E. A., Liberman, L., Ballon, D. J., La Trenta, L. R., Hadar, O., Abramson, A., and Dershaw, D. D. Observer Variability and Applicability of BI-RADS Terminology for Breast MR Imaging: Invasive Carcinomas as Focal Masses. Am. J. Roentgenol. 177, 551-557 (2001).
42. Rieber, A., Merkle, E., Bohm, W., Brambs, H. J., and Tomczak, R. MRI of Histologically Confirmed Mammary Carcinoma: Clinical Relevance of Diagnostic Procedures for Detection of Multifocal or Contralateral Secondary Carcinoma. J. Comput. Assist. Tomogr. 21, 773-779 (1997).
43. Slanetz, P. J., Edmister, W. B., Yeh, E. D., Talele, A. C., and Kopans, D. B. Occult Contralateral Breast Carcinoma Incidentally Detected by Breast Magnetic Resonance Imaging. The Breast Journal 8, 145 (2002).
44. Drew, P. J., Chatterjee, S., Turnbull, L. W., Read, J., Carleton, P. J., Fox, J. N., Monson, J. R., and Kerin, M. J. Dynamic Contrast Enhanced Magnetic Resonance Imaging of the Breast is Superior to Triple Assessment for the Pre-operative Detection of Multifocal Breast Cancer. Ann. Surg. Oncol. 6, 599-603 (1999).
45. Tillman, G. F., Orel, S. G., Schnall, M. D., Schultz, D. J., Tan, J. E., and Solin, L. J. Effect of Breast Magnetic Resonance Imaging on the Clinical Management of Women with Early-stage Breast Carcinoma. J. Clin. Oncol. 20, 3413-3423 (2002).
46. Bedrosian, I., Mick, R., Orel, S. G., Schnall, M., Reynolds, C., Spitz, F. R., Callans, L. S., Buzby, G. P., Rosato, E. F., Fraker, D. L., and Czerniecki, B. J. Changes in the Surgical Management of Patients with Breast Carcinoma Based on Preoperative Magnetic Resonance Imaging. Cancer 98, 468-473 (2003).
47. Hlawatsch, A., Teifke, A., Schmidt, M., and Thelen, M. Preoperative Assessment of Breast Cancer: Sonography Versus MR Imaging. Am. J. Roentgenol. 179, 1493-1501 (2002).
48. Liberman, L., Morris, E. A., Kim, C. M., Kaplan, J. B., Abramson, A. F., Menell, J. H., Van Zee, K. J., and Dershaw, D. D. MR Imaging Findings in the Contralateral Breast of Women with Recently Diagnosed Breast Cancer. Am. J. Roentgenol. 180, 333-341 (2003).
49. Hata, T., Takahashi, H., Watanabe, K., Takahashi, M., Taguchi, K., Itoh, T., and Todo, S. Magnetic Resonance Imaging for Preoperative Evaluation of Breast Cancer: A Comparative Study with Mammography and Ultrasonography. J. Am. Coll. Surg. 198, 190-197 (2004).
50. Morrow, M. Magnetic Resonance Imaging in the Preoperative Evaluation of Breast Cancer: Primum non nocere. J. Am. Coll. Surg. 198, 240-241 (2004).
51. Hollingsworth, A. B. Perspectives on Preoperative Staging with Breast MRI. J. Am. Coll. Surg. 199, 173-174 (2004).
52. Egan, R. L. Multicentric Breast Carcinomas: Clinical-radiographic- pathologic Whole Organ Studies and 10-year Survival. Cancer. 49, 1123-1130 (1982).
53. Vaidya, J. S., Tobias, J. S., Baum, M., Keshtgar, M., Joseph, D., Wenz, F., Houghton, J., Saunders, C., Corica, T., D'Souza, D., Sainsbury, R., Massarut, S., Taylor, I., and Hilaris, B. Intraoperative Radiotherapy for Breast Cancer. Lancet Oncol. 5, 165-173 (2004).
54. Bartelink, H. Intraoperative Radiotherapy for Breast Cancer: Tail Wagging the Dog? Lancet Oncol. 5, 207-208 (2004).
55. Fisher, E. R., Anderson, S., Tan-Chiu, E., Fisher, B., Eaton, L., and Wolmark, N. Fifteen-year Prognostic Discriminants for Invasive Breast Carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06. Cancer 91 (8 Suppl), 1679-1687 (2001).
56. Cuncins-Heam, A., Saunders, C., Walsh, D., Borg, M., Buckingham, J., Frizelle, F., and Maddern, G. A Systematic Review of Intraoperative Radiotherapy in Early Breast Cancer. Breast Cancer Res. Treat. 85, 271-280 (2004).
57. Kvistad, K. A., Rydland, J., Smethurst, H. B., Lundgren, S., Fjosne, H. E., and Haraldseth, O. Axillary Lymph Node Metastases in Breast Cancer: Preoperative Detection with Dynamic Contrast-enhanced MRI. Eur. Radiol. 10, 1464-1471 (2000).
58. Silverstein, M. J., Skinner, K. A., and Lomis, T. J. Predicting Axillary Nodal Positivity in 2282 Patients with Breast Carcinoma. World J. Surg. 25, 767-772 (2001).
59. Stavros, A. T. Evaluation of Regional Lymph Nodes in Breast Cancer Patients, In Breast Ultrasound, pp. 834-876. Ed. Stavros, A. T. Lippincott Williams & Wilkins, Philadelphia, PA (2004).
60. Luciani, A., Dao, T. H., Lapeyre, M., Schwarzinger, M., Debaecque, C., Lantieri, L., Revelon, G., Bouanane, M., Kobeiter, H., and Rahmouni, A. Simultaneous Bilateral Breast and High-resolution Axillary MRI of Patients with Breast Cancer: Preliminary Results. Am. J. Roentgenol. 182, 1059-1067 (2004).
61. Yeung, D. K., Yang, W. T., and Tse, G. M. Breast Cancer: In Vivo Proton MR Spectroscopy in the Characterization of Histopathologic Subtypes and Preliminary Observations in Axillary Node Metastases. Radiology 225, 190-197 (2002).
62. Michel, S. C., Keller, T. M., Frohlich, J. M., Fink, D., Caduff, R., Seifert, B., Marincek, B., and Kubik-Huch, R. A. Preoperative Breast Cancer Staging: MR Imaging of the Axilla with Ultrasmall Superparamagnetic Iron Oxide Enhancement. Radiology 225, 527-536 (2002).
63. Yamagami, T., Yuen, S., Sawai, K., and Nishimura T. MR Imaging-guided Axillary Node Biopsy for Breast Cancer: Initial Findings. Eur. Radiol. 14, 151-156 (2004).
64. Rieber, A., Zeitler, H., Rosenthal, H., Gorich, J., Kreienberg, R., Brambs, H. J., and Tomczak, R. MRI of Breast Cancer: Influence of Chemotherapy on Sensitivity. Br. J. Radiol. 70, 452-458 (1997).
65. Ikeda, T., Jinno, H., Matsu, A., Masamura, S., and Kitajima, M. The Role of Neoadjuvant Chemotherapy for Breast Cancer Treatment. Breast Cancer 9, 8-14 (2002).
66. Londero, V., Bazzocchi, M., Del Frate, C., Puglisi, F., Di Loreto, C., Francescutti, G., and Zuiani, C. Locally Advanced Breast Cancer: Comparison of Mammography, Sonography and MR Imaging in Evaluation of Residual Disease in Women Receiving Neoadjuvant Chemotherapy. Eur. Radiol. 14, 1371-1379 (2004).
67. Partridge, S. C., Gibbs, J. E., Lu, Y., Esserman, L. J., Sudilovsky, D., and Hylton, N. M. Accuracy of MR Imaging for Revealing Residual Breast Cancer in Patients Who Have Undergone Neoadjuvant Chemotherapy. Am. J. Roentgenol. 179, 1193-1199 (2002).
68. Wasser, K., Klein, S. K., Fink, C., Junkermann, H., Sinn, H. P., Zuna, I., Knopp, M. V., and Delorme, S. Evaluation of Neoadjuvant Chemotherapeutic Response of Breast Cancer Using Dynamic MRI with High Temporal Resolution. Eur. Radiol. 13, 80-87 (2002).
69. Rosen, E. L., Blackwell, K. L., Baker, J. A., Soo, M. S., Bentley, R. C., Yu, D., Samulski, T. V., and Dewhirst, M. W. Accuracy of MRI in the Detection of Residual Breast Cancer after Neoadjuvant Chemotherapy. Am. J. Roentgenol. 181, 1275-1282 (2003).
70. Martincich, L., Montemurro, F., De Rosa, G., Marra, V., Ponzone, R., Cirillo, S., Gatti, M., Biglia, N., Sarotto, I., Sismondi, P., Regge, D., and Aglietta, M. Monitoring Response to Primary Chemotherapy in Breast Cancer using Dynamic Contrast-enhanced Magnetic Resonance Imaging. Breas. Cancer Res. Treat. 83, 67-76 (2004).
71. Fisher, E. R., Dignam, J., Tan-Chiu, E., Costantino, J., Fisher, B., Paik, S., and Wolmark, N. Pathologic Findings from the National Surgical Adjuvant Breast Project (NSABP) Eight-year Update of Protocol B-17: Intraductal Carcinoma. Cancer 86, 429-438 (1999).
72. Fisher, B., Redmond, C., Poisson, R., Margolese, R., Wolmark, N., Wickerham, L., Fisher, E., Deutsch, M., Caplan, R., and Pilch, Y. Eight-year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer. N. Engl. J. Med. 320, 822-828 (1989).
73. Orel, S. G., Reynolds, C., Schnall, M. D., Solin, L. J., Fraker, D. L., and Sullivan, D.C. Breast Carcinoma: MR Imaging Before Re-excisional Biopsy. Radiology 205, 429-436 (1997).
74. Frei, K. A., Kinkel, K., Bonel, H. M., Lu, Y., Esserman, L. J., Hylton, N. M. MR Imaging of the Breast in Patients with Positive Margins after Lumpectomy: Influence of the Time Interval between Lumpectomy and MR Imaging. Am. J. Roentgenol. 175, 1577-1584 (2000).
75. Soderstrom, C. E., Harms, S. E., Farrell, R. S. Jr, Pruneda, J. M., and Flamig, D. P. Detection with MR Imaging of Residual Tumor in the Breast Soon after Surgery. Am. J. Roentgenol. 168, 485-488 (1997).
76. Heywang-Kobrunner, S. H., Schlegel, A., Beck, R., Wendt, T., Kellner, W., Lommatzsch, B., Untch, M., Nathrath, W. B. Contrast-enhanced MRI of the Breast after Limited Surgery and Radiation Therapy. J. Comput. Assist. Tomogr. 17, 891-900 (1993).
77. Drew, P. J., Kerin, M. J., Turnbull, L. W., Imrie, M., Carleton, P. J., Fox, J. N., and Monson, J. R. Routine Screening for Local Recurrence Following Breast-conserving Therapy for Cancer with Dynamic Contrast-enhanced Magnetic Resonance Imaging of the Breast. Ann. Surg. Oncol. 5, 265-270 (1998).
78. Rieber, A., Merkle, E., Zeitler, H., Gorich, J., Kreienberg, R., Brambs, H. J., and Tomczak, R. Value of MR Mammography in the Detection and Exclusion of Recurrent Breast Carcinoma. J. Comput. Assist. Tomogr. 21, 780-784 (1997).
79. Stuhrmann, M., Aronius, R., and Schietzel, M. Tumor Vascularity of Breast Lesions: Potentials and Limits of Contrast-enhanced Doppler Sonography. Am. J. Roentgenol. 175, 1585-1589 (2000).
80. Helbich, T. H., Matzek, W., and Fuchsjager, M. H. Stereotactic and Ultrasound-guided Breast Biopsy. Eur. Radiol. 14, 383-393 (2003).
81. Daniel, B. L., Birdwell, R. L., Butts, K., Nowels, K. W., Ikeda, D. M., Heiss, S. G., Cooper, C. R., Jeffrey, S. S., Dirbas, F. M., and Herfkens, R. J. Freehand iMRI-guided Large-gauge Core Needle Biopsy: A New Minimally Invasive Technique for Diagnosis of Enhancing Breast Lesions. J. Magn. Reson. Imaging 13, 896-902 (2001).
82. Heywang-Kobrunner, S. H., Heinig, A., Pickuth, D., Alberich, T., and Spielmann, R. P. Interventional MRI of the Breast: Lesion Localisation and Biopsy. Eur. Radiol. 10, 36-45 (2000).
83. Viehweg, P., Heinig, A., Amaya, B., Alberich, T., Laniado, M., Heywang-Kobrunner, S. H. MR-guided Interventional Breast Procedures Considering Vacuum Biopsy in Particular. Eur. J. Radiol. 42, 32-39 (2002).
84. Morris, E. A., Liberman, L., Dershaw, D. D., Kaplan, J. B., LaTrenta, L. R., Abramson, A. F., and Ballon, D. J. Preoperative, MR Imaging-guided Needle Localization of Breast Lesions. Am. J. Roentgenol. 178, 1211-1220 (2002).
85. Orel, S. G., Schnall, M. D., Newman, R. W., Powell, C. M., Torosian, M. H., and Rosato, E. F. MR Imaging-guided Localization and Biopsy of Breast Lesions: Initial Experience. Radiology 193, 97-102 (1994).
86. Orel, S. G., Schnall, M. D., Newman, R. W., Powell, C. M., Torosian, M. H., and Rosato, E. F. MR Imaging-guided Localization and Liopsy of Breast Lesions: Initial Experience. Radiology 193, 97-102 (1994).
87. Daniel, B. L., Birdwell, R. L., Ikeda, D. M., Jeffrey, S. S., Black, J. W., Block, W.,F., Sawyer-Glover, A. M., Glover, G. H., and Herfkens, R. J. Breast Lesion Localization: A Freehand, Interactive MR Imaging-guided Technique. Radiology 207, 455-463 (1998).
88. Prat, X., Sittek, H., Grosse, A., Baath, L., Perlet, C., Alberich, T., Lamarque, J. M., Andersson, I., Reiser, M., Taourel, P., Fischer, H., and Heywang-Kobrunner, S. H. European Quadricentric Evaluation of a Breast MR Biopsy and Localization Device: Technical Improvements Based on Phase-I Evaluation. Eur. Radiol. 12, 1720-1727 (2002).
89. Kuhl, C. K., Elevelt, A., Leutner, C. C., Gieseke, J., Pakos, E., Schild, H. H. Interventional Breast MR Imaging: Clinical Use of a Stereotactic Localization and Biopsy Device. Radiology 204, 667-675 (1997).
90. Hefler, L., Casselman, J., Amaya, B., Heinig, A., Alberich, T., Koelbl, H., and Heywang-Kobrunner, S. H. Follow-up of Breast Lesions Detected by MRI not Biopsied due to Absent Enhancement of Contrast Medium. Eur. Radiol. 13, 344-346 (2003).
91. Chen, X., Lehman, C. D., and Dee, K. E. MRI-guided Breast Biopsy: Clinical Experience with 14-gauge Stainless Steel Core Biopsy Needle. Am. J. Roentgenol. 182, 1075-1080 (2004).
92. Kuhl, C. K., Morakkabati, N., Leutner, C. C., Schmiedel, A., Wardelmann, E., and Schild, H. H. MR Imaging-guided Large-core (14-gauge) Needle Biopsy of Small Lesions Visible at Breast MR Imaging Alone. Radiology 220, 31-39 (2001).
93. Perlet, C., Schneider, P., Amaya, B., Grosse, A., Sittek, H., Reiser, M. F., and Heywang-Kobrunner, S. H. MR-guided Vacuum Biopsy of 206 Contrast-enhancing Breast Lesions. Rofo. Fortschr. Geb. Rontgenstr. 174, 88-95 (2002).
94. Liberman, L., Morris, E. A., Dershaw, D. D., Thornton, C. M., Van Zee, K. J., and Tan, L. K. Fast MRI-guided Vacuum-assisted Breast Biopsy: Initial Experience. Am. J. Roentgenol. 181, 1283-1293 (2003).
95. Huber, P. E., Jenne, J. W., Rastert, R., Simiantonakis, I., Sinn, H. P., Strittmatter, H. J., von Fournier, D., Wannenmacher, M. F., and Debus, J. A New Noninvasive Approach in Breast Cancer Therapy Using Magnetic Resonance Imaging-guided Fcused Ultrasound Surgery. Cancer Res. 61, 8441-8447 (2001).
96. Gianfelice, D., Khiat, A., Amara, M., Belblidia, A., and Boulanger, Y. MR Imaging-guided Focused Ultrasound Surgery of Breast Cancer: Correlation of Dynamic Contrast-enhanced MRI with Histopathologic Findings. Breast Cancer Res. Treat. 82, 93-101 (2003).
97. Lukas, L., Devos, A., Suykens, J. A., Vanhamme, L., Howe, F. A., Majos, C., Moreno-Torres, A., Van der Graaf, M., Tate, A. R., Arus, C., and Van Huffel, S. Brain Tumor Classification Based on Long Echo Proton MRS Signals. Artif. Intell. Med. 31, 73-89 (2004).
98. 1H MR Spectra. J. Magn. Reson. 170, 164-175 (2004).
99. Katz-Brull, R., Lavin, P. T., and Lenkinski, R. E. Clinical Utility of Proton Magnetic Resonance Spectroscopy in Characterizing Breast Lesions. J. Natl. Cancer Inst. 94, 1197-1203 (2002).
100. Cousins, J. P. Clinical MR Spectroscopy: Fundamentals, Current Applications, and Future Potential. Am. J. Roentgenol. 164, 1337-1347 (1995).
101. Yeh, E. D. Characterization of Breast Lesions with Proton MR Spectroscopy. Am. J. Roentgenol. 181, 1273-1274 (2003).
102. Yeung, D. K., Cheung, H. S., Tse, G. M. Human Breast Lesions: Characterization with Contrast-enhanced In Vivo Proton MR Spectroscopy - Initial Results. Radiology 220, 40-46 (2001).
103. Thomas, M. A., Binesh, N., Yue, K., and DeBruhl, N. Volume-localized Two-dimensional Correlated Magnetic Resonance Spectroscopy of Human Breast Cancer. J. Magn. Reson. Imaging. 14, 181-186 (2001).
104. Cecil, K. M., Schnall, M. D., Siegelman, E. S., and Lenkinski, R. E. The Evaluation of Human Breast Lesions with Magnetic Resonance Imaging and Proton Magnetic Resonance Spectroscopy. Breast Cancer Res. Treat. 68, 45-54 (2001).
105. Tse, G. M., Cheung, H. S., Pang, L. M., Chu, W. C., Law, B. K., Kung, F. Y., and Yeung, D. K. Characterization of Lesions of the Breast with Proton MR Spectroscopy: Comparison of Carcinomas, Benign Lesions, and Phyllodes Tumors. Am. J. Roentgenol. 181, 1267-1272 (2003).
106. Jacobs, M. A., Barker, P. B., Bottomley, P. A., Bhujwalla, Z., and Bluemke, D. A. Proton Magnetic Resonance Spectroscopic Imaging of Human Breast Cancer: A Preliminary Study. J. Magn. Reson. Imaging 19, 68-75 (2004).
107. Huang, W., Fisher, P. R., Dulaimy, K., Tudorica, L. A., O'Hea, B., and Button, T. M. Detection of Breast Malignancy. Diagnostic MR Protocol for Improved Specificity. Radiology 232, 585-591 (2004).
108. Kvistad, K. A., Rydland, J., Vainio, J., Smethurst, H. B., Lundgren, S., Fjosne, H. E., and Haraldseth, O. Breast Lesions: Evaluation with Dynamic Contrast-enhanced T1-weighted MR Imaging and with T2*-weighted First-pass Perfusion MR Imaging. Radiology 216, 545-553 (2000).
109. Duffy, S. W., Tabar, L., Chen, H. H., Holmqvist, M., Yen, M. F., Abdsalah, S., Epstein, B., Frodis, E., Ljungberg, E., Hedborg-Melander, C., Sundbom, A., Tholin, M., Wiege, M., Akerlund, A., Wu, H. M., Tung, T. S., Chiu, Y. H., Chiu, C. P., Huang, C. C., Smith, R. A., Rosen, M., Stenbeck, M., and Holmberg, L. The Impact of Organized Mammography Service Screening on Breast Carcinoma Mortality in Seven Swedish Counties. Cancer 95, 458-469 (2002).
110. Kopans, D. B. Updated Results of the Trials of Screening Mammography. Surg. Oncol. Clin. N. Am. 6, 233-263 (1997).
111. Nystrom, L., Andersson, I., Bjurstam, N., Frisell, J., Nordenskjold, B., and Rutqvist, L. E. Long-term Effects of Mammography Screening: Updated Overview of the Swedish Randomised Trials. Lancet 359, 909-919 (2002).
112. Kopans, D. B. The Most Recent Breast Cancer Screening Controversy about Whether Mammographic Screening Benefits Women at Any Age: Nonsense and Nonscience. Am. J. Roentgenol. 180, 21-26 (2003).
113. Irwig, L., Houssami, N., and van Vliet, C. New Technologies in Screening for Breast Cancer: A Systematic Review of Their Accuracy. Br. J. Cancer 90, 2118-2122 (2004).
114. Morris, E. A., Liberman, L., Ballon, D. J., Robson, M., Abramson, A. F., Heerdt, A., and Dershaw, D. D. MRI of Occult Breast Ccarcinoma in a High-risk Population. Am. J. Roentgenol. 181, 619-626 (2003).
115. Ford, D. and Easton, D. F. The Genetics of Breast and Ovarian Cancer. Br. J. Cancer 72, 805-812 (1995).
116. Kuhl, C. K., Schmutzler, R. K., Leutner, C. C., Kempe, A., Wardelmann, E., Hocke, A., Maringa, M., Pfeifer, U., Krebs, D., and Schild, H. H. Breast MR Imaging Screening in 192 Women Proved or Suspected to be Carriers of a Breast Cancer Susceptibility Gene: Preliminary Results. Radiology 215, 267-279 (2000).
117. Kerlikowske, K., Carney, P. A., Geller, B., Mandelson, M. T., Taplin, S. H., Malvin, K., Ernster, V., Urban, N., Cutter, G., Rosenberg, R., and Ballard-Barbash, R. Performance of Screening Mammography Among Women With and Without a First-degree Relative With Breast Cancer. Ann. Intern. Med. 133, 855-863 (2000).
118. Lakhani, S. R., Jacquemier, J., Sloane, J. P., Gusterson, B. A., Anderson, T. J., van de Vijver, M. J., Farid, L. M., Venter, D., Antoniou, A., Storfer-Isser, A., Smyth, E., Steel, C. M., Haites, N., Scott, R. J., Goldgar, D., Neuhausen, S., Daly, P. A., Ormiston, W., McManus, R., Scherneck, S., Ponder, B. A., Ford, D., Peto, J., Stoppa-Lyonnet, D., and Easton, D. F. Multifactorial Analysis of Differences between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 Mutations. J. Natl. Cancer Inst. 90, 1138-1145 (1998).
119. Burke, W., Daly, M., Garber, J., Botkin, J., Kahn, M. J., Lynch, P., McTiernan, A., Offit, K., Perlman, J., Petersen, G., Thomson, E., and Varricchio, C. Recommendations for Follow-up Care of Individuals with an Inherited Predisposition to Cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. J.A.M.A. 277, 997-1003 (1997).
120. Goscin, C. P., Berman, C. G., and Clark, R. A. Magnetic Resonance Imaging of the Breast. Cancer Control 8, 399-406 (2001).
121. Kriege, M., Brekelmans, C. T., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Peterse, H., Tilanus-Linthorst, M. M., Muller, S. H., Meijer, S., Oosterwijk, J. C, Beex, L. V., Tollenaar, R. A., de Koning, H. J., Rutgers, E. J., and Klijn, J. G. Magnetic Resonance Imaging Screening Study Group. Efficacy of MRI and Mammography for Breast-cancer Screening in Women with a Familial or Genetic Predisposition. N. Engl. J. Med. 351, 427-437 (2004).